mRNA技术在传染病和病毒诱发癌症疫苗研发中的潜在优势和局限性
收藏国家科技图书文献中心2026-05-09 收录
下载链接：
http://portal.nstl.gov.cn/reportFront/getReportDetailFront.htm?serverId=26&uuid=d8a9e69e08ad1b98bf37b734eefa3535
下载链接
链接失效反馈官方服务：
资源简介：
ThereportrecommendsaframeworktoassessthevalueofmRNAtechnologyindevelopingvaccinesandtherapeuticsagainstotherinfectiousdiseases.Aframeworkcouldalsohelpestablishthetechnology’spotentialroleinaddressingcancerandautoimmunediseases.Toinformsuchaframework,thereportmapsouttheclinicaltrialstatusofmRNAvaccinesinthemostadvancedstagesofdevelopment.WhiletheCOVID-19vaccinesaretheonlysafeandefficaciouspreventivemRNAvaccinesdevelopedandapprovedforhumanusetodate,mRNAvaccinesagainstcytomegalovirus(acommonvirusthatcanthreatenbabiesandthosewithaweakenedimmunesystem),influenzaAandB,andRSVareinPhase3trials.Thereisalsoon-goingdiscoveryworkintuberculosis,malaria,HIVaswellasnoncommunicablediseases.Thereportalsocallsforfurtherresearchtoaddressthepotentialofthistechnologyaswellasitslimitations.ImprovingthestabilityofmRNAvaccinesathighertemperaturesshouldbeakeytargetofinvestmentandresearchefforts.Anotherkeyrecommendationisensuringend-to-enddevelopmentandaccessbywayofinvestmentandapplyinglessonsfromCOVID-19initiatives,suchastheACT-Accelerator,whichworkedtosecureaccesstoCOVID-19tests,treatments,andvaccines.
提供机构：
世界卫生组织（WHO）
